Literature DB >> 1865403

Necrotizing fasciitis in irradiated tissue from diabetic women. A report of two cases.

C H Livengood1, J T Soper, D L Clarke-Pearson, W A Addison.   

Abstract

Two diabetic women with pelvic malignancies developed necrotizing fasciitis within the irradiation fields. Despite aggressive surgical and medical therapy, both died when their health became too unstable for them to tolerate further surgery to resect the residual infection. We attribute their poor outcome to several factors. First, postradiation tissue changes obscured the early clinical findings necessary for a prompt diagnosis and made the identification of adequate surgical margins difficult. Second, diabetic patients have increased susceptibility to this infection. Third, the cumulative effects of radiation, diabetes mellitus and other factors that are common in patients with gynecologic malignancy (advanced age, vascular disease, obesity) favor the development, progression and persistence of necrotizing fasciitis. Radiographic studies were helpful in defining the extent of the infection in one patient.

Entities:  

Mesh:

Year:  1991        PMID: 1865403

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  3 in total

Review 1.  Postirradiation Klebsiella pneumoniae-associated necrotizing fasciitis in the western hemisphere: a rare but life-threatening clinical entity.

Authors:  Theodoros Kelesidis; Sotirios Tsiodras
Journal:  Am J Med Sci       Date:  2009-09       Impact factor: 2.378

2.  Necrotizing fasciitis: a review of management guidelines in a large obstetrics and gynecology teaching hospital.

Authors:  C D Thompson; A L Brekken; W H Kutteh
Journal:  Infect Dis Obstet Gynecol       Date:  1993

3.  Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma.

Authors:  Mehmet A N Sendur; Sercan Aksoy; Nuriye Yıldırım Özdemir; Nurullah Zengin
Journal:  Indian J Pharmacol       Date:  2014 Jan-Feb       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.